David S. Tierney - 13 Aug 2021 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Director
Signature
/s/ David S. Tierney
Issuer symbol
CPRX
Transactions as of
13 Aug 2021
Net transactions value
-$147,895
Form type
4
Filing time
17 Aug 2021, 16:48:59 UTC
Previous filing
21 Jun 2021
Next filing
30 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $156,000 +50,000 +16% $3.12 356,874 13 Aug 2021 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $303,895 -50,000 -14% $6.08 306,874 13 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -50,000 -14% $0.000000 306,167 13 Aug 2021 Common Stock 50,000 $3.12 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Dr. Tierney has advised the Company that the sale of shares was to raise funds for personal reasons and does not relate to any disagreements with the Company on any matter relating to the Company's operations, policies or practices. Dr. Tierney remains a Director of the Company.
F2 The option was granted on August 28, 2014 and previously vested in two equal annual installments.